Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01883635 · ClinicalTrials.gov registry record · Phase 1

Exercise Intervention for Cancer Survivors and Caregivers

A Phase 1 study, sponsored by University of Rochester.

Completed
Registry status
Phase 1
Development phase
44
Enrollment target

NCT01883635: Completed Phase 1 study, sponsored by University of Rochester.

NCT01883635 is a Phase 1 study that has completed, run by University of Rochester. The registered enrollment target is 44 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01883635, a Phase 1 study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
Phase 1
Development phase
44 participants
Enrollment target

Study Summary

The purpose of the study is to see whether exercise can improve the health and well-being of cancer survivors. We also want to know about the health and well being of caregivers.

Primary Outcome

Change in psychological distress in the cancer survivor from baseline to 6 weeks, as measured by the Profile of Moods States (POMS) total score. At each time point (baseline and 6 weeks), this questionnaire had a total score range of 0-200, with lower scores signifying less distress. We subtracted the baseline POMS score from the 6 week POMS score; the change score reported below thus has a range from -200 to 200, with lower scores signifying less distress.

Interventions

  • BEHAVIORAL Survivor-only progressive walking and resistance exercise
  • BEHAVIORAL Dyadic progressive walking and resistance exercise

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2013-05
Est. Completion 2015-08
Phase Phase 1
University of Rochester

636 total trials

What the finished NCT01883635 record still lists

NCT01883635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% lower).

The record links to 0 conditions, and to 2 interventions - of which Survivor-only progressive walking and resistance exercise is the first listed.

NCT01883635 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01883635 about?

NCT01883635 is a clinical study titled "Exercise Intervention for Cancer Survivors and Caregivers". The purpose of the study is to see whether exercise can improve the health and well-being of cancer survivors. We also want to know about the health and well being of caregivers.

What is the current status of trial NCT01883635?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2013-05. Estimated completion is 2015-08.

What interventions are being tested in trial NCT01883635?

The interventions under investigation include: Survivor-only progressive walking and resistance exercise (BEHAVIORAL), Dyadic progressive walking and resistance exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01883635?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01883635's enrollment target sits among peer trials

44 1086th of 2000 higher than 901 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01883635, the US trial registry maintained by the National Library of Medicine. NCT01883635 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.